Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Immunoglobulins during different treatment regimes in Schnitzler's syndrome.

Thonhofer R.

Rheumatol Int. 2011 Dec;31(12):1665-7. doi: 10.1007/s00296-010-1681-1. Epub 2010 Dec 2. No abstract available.

PMID:
21125280
2.

Schnitzler's syndrome improvement after anti-TNF-alpha therapy.

Aikawa NE, Silva CA, Bonfá E, Carvalho JF.

Joint Bone Spine. 2010 Oct;77(5):491. doi: 10.1016/j.jbspin.2010.02.016. Epub 2010 May 15. No abstract available.

PMID:
20478726
3.

[Schnitzler's syndrome: a case report and literature review of the response to treatment with anakinra].

Benítez Gutiérrez L, Mellor Pita S, Tutor de Ureta P, Yebra Bango M.

Med Clin (Barc). 2013 May 4;140(9):427-8. doi: 10.1016/j.medcli.2012.09.003. Epub 2012 Nov 22. Review. Spanish. No abstract available.

PMID:
23177777
4.

Comment on: Schnitzlers syndrome--exacerbation after anti-TNF treatment.

de Koning HD, van der Meer JW, Simon A.

Rheumatology (Oxford). 2007 Nov;46(11):1741 author reply 1741. No abstract available.

PMID:
17956920
5.

Treatment of Schnitzler's syndrome with anakinra.

Gilson M, Abad S, Larroche C, Dhote R.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6):931. No abstract available.

PMID:
18173934
6.

Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.

Kluger N, Rivière S, Guillot B, Bessis D.

Acta Derm Venereol. 2008;88(3):287-8. doi: 10.2340/00015555-0404. No abstract available.

7.

Delayed development of the IgM paraprotein in Schnitzler's syndrome.

Mulla E, Neame R.

Scand J Rheumatol. 2015;44(6):521-2. doi: 10.3109/03009742.2015.1071421. Epub 2015 Sep 23. No abstract available.

PMID:
26395927
8.

Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.

Jani M, Chinoy H, Warren RB, Griffiths CE, Plant D, Fu B, Morgan AW, Wilson AG, Isaacs JD, Hyrich K, Barton A; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Collaborators.

Arthritis Rheumatol. 2015 May;67(8):2011-9. doi: 10.1002/art.39169. Erratum in: Arthritis Rheumatol. 2015 Nov;67(11):3096.

9.

Immunotherapies in rheumatologic disorders.

Miller AV, Ranatunga SK.

Med Clin North Am. 2012 May;96(3):475-96, ix-x. doi: 10.1016/j.mcna.2012.04.003. Epub 2012 May 1. Review.

PMID:
22703852
10.

Treatment, management, and monitoring of established rheumatoid arthritis.

Bingham CO 3rd, Miner MM.

J Fam Pract. 2007 Oct;56(10 Suppl Rapid):S1-7; quiz S8. Review. No abstract available.

PMID:
17949607
11.

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α.

Onishi S, Yoshio T, Nagashima T, Minota S.

Mod Rheumatol. 2010 Oct;20(5):528-30. doi: 10.1007/s10165-010-0305-7. Epub 2010 May 12. No abstract available.

PMID:
20458607
12.

Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature.

Gran JT, Midtvedt Ø, Haug S, Aukrust P.

Scand J Rheumatol. 2011 Jan;40(1):74-9. doi: 10.3109/03009742.2010.493894. Epub 2010 Oct 11. Review. No abstract available.

PMID:
20936987
13.

Successful use of anakinra to treat refractory Schnitzler's syndrome.

Dybowski F, Sepp N, Bergerhausen HJ, Braun J.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):354-7.

PMID:
18565263
14.

Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.

Chu DH, Van Voorhees AS, Rosenbach M.

Arch Dermatol. 2011 Oct;147(10):1228-30. doi: 10.1001/archdermatol.2011.275. No abstract available.

PMID:
22006150
16.

[Schnitzler syndrome: A dramatic improvement with anakinra].

Billey T, Beldjerd M, Popa L, Lassoued S.

Presse Med. 2010 Dec;39(12):1338-9. doi: 10.1016/j.lpm.2010.07.009. Epub 2010 Sep 15. French. No abstract available.

PMID:
20832239
17.

Etanercept in rheumatoid arthritis.

Cook DA, Dimick JB, Gallagher DC.

N Engl J Med. 1999 Jun 24;340(25):2000; author reply 2001. No abstract available.

18.

Optimizing outcomes in rheumatoid arthritis.

Small RE, Schuna A.

J Am Pharm Assoc (2003). 2003 Sep-Oct;43(5 Suppl 1):S16-7.

PMID:
14626516
19.

Partial response to cyclosporine in a patient with Schnitzler's syndrome.

Carbone J, Paravisini A, Sarmiento E, Rodríguez-Molina J, Fernández-Cruz E.

Allergol Immunopathol (Madr). 2007 Mar-Apr;35(2):71-3.

PMID:
17428403
20.

Schnitzler's syndrome: successful treatment with anakinra.

Crouch R, Akhras V, Sarkany R.

Australas J Dermatol. 2007 Aug;48(3):178-81.

PMID:
17680970

Supplemental Content

Support Center